Login / Signup

Epigenetic silencing of miR-1271 enhances MEK1 and TEAD4 expression in gastric cancer.

Byungho LimHee-Jin KimHaejeong HeoNanhyung HuhSu-Jin BaekJong-Hwan KimDong-Hyuck BaeEun-Hye SeoSang-Il LeeKyu-Sang SongSeon-Young KimYong Sung KimMirang Kim
Published in: Cancer medicine (2018)
Epigenetic dysregulation is a major driver of tumorigenesis. To identify tumor-suppressive microRNAs repressed by DNA methylation in gastric cancer (GC), we analyzed the genome-wide DNA methylation and microRNA expression profiles of EpCAM+/CD44+ GC cells. Among the set of microRNAs screened, miR-1271 was identified as a microRNA repressed by DNA methylation in GC. Forced miR-1271 expression substantially suppressed the growth, migration, and invasion of GC cells. To identify candidate target genes and signaling pathways regulated by miR-1271, we performed RNA sequencing. Among the genes down-regulated by miR-1271, MAP2K1 (MEK1) was significantly repressed by miR-1271, and the associated ERK/MAPK signaling pathway was also inhibited. TEAD4 was also repressed by miR-1271, and the associated YAP1 signatures within genes regulated by miR-1271 were significantly enriched. These findings uncovered MEK1 and TEAD4 as novel miR-1271 targets and suggest that the epigenetic silencing of miR-1271 is crucial for GC development.
Keyphrases